Akihiko Sano

3.6k total citations
151 papers, 2.7k citations indexed

About

Akihiko Sano is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Akihiko Sano has authored 151 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 50 papers in Pulmonary and Respiratory Medicine and 46 papers in Oncology. Recurrent topics in Akihiko Sano's work include Gastric Cancer Management and Outcomes (37 papers), Esophageal Cancer Research and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Akihiko Sano is often cited by papers focused on Gastric Cancer Management and Outcomes (37 papers), Esophageal Cancer Research and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Akihiko Sano collaborates with scholars based in Japan, United States and Australia. Akihiko Sano's co-authors include Makoto Sohda, Makoto Sakai, Shunji Nagahara, Miho Maeda, Hiroyuki Kuwano, Naritaka Tanaka, Takanori Inose, Masanobu Nakajima, Tatsuya Miyazaki and Keiji Fujioka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Akihiko Sano

132 papers receiving 2.6k citations

Peers

Countries citing papers authored by Akihiko Sano

Since Specialization

Citations

This map shows the geographic impact of Akihiko Sano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Sano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Sano more than expected).

Fields of papers citing papers by Akihiko Sano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Sano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Sano. The network helps show where Akihiko Sano may publish in the future.

Co-authorship network of co-authors of Akihiko Sano

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Sano. A scholar is included among the top collaborators of Akihiko Sano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Sano. Akihiko Sano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benefit of laparoscopic two-team transanal beyond total mesorectal excision for advanced and recurrent rectal cancer with invasion: a retrospective study compared with conventional laparoscopic approach 2025 ·Techniques in Coloproctology ·(unknown), Takuya Shiraishi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takuhisa Okada, Akiharu Kimura, Akihiko Sano, Makoto Sakai, Ken Shirabe, Hiroshi Saeki	0
2	Poorly cohesive gastric cancer with increased epithelial‑mesenchymal transition is associated with a poor prognosis 2024 ·Oncology Letters ·Nobuhiro Nakazawa, Makoto Sohda, Munenori Ide, (unknown), Akihiko Sano, Makoto Sakai, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki	0
3	Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer: a systematic review and meta-analysis 2024 ·Esophagus ·Makoto Sakai, Makoto Sohda, (unknown), (unknown), Takayoshi Watanabe, Hideyuki Saito, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, Hiroomi Ogawa, Takehiko Yokobori, Kazue Nagai, Ken Shirabe, (unknown)	2
4	The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients 2024 ·Cancer Chemotherapy and Pharmacology ·Nobuhiro Nakazawa, Makoto Sohda, Mizuki Endo, (unknown), (unknown), Takayoshi Watanabe, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, Hiroshi Saeki	0
5	Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer 2024 ·Oncology Letters ·(unknown), (unknown), Takuya Shiraishi, Makoto Sohda, (unknown), (unknown), (unknown), (unknown), Nobuhiro Nakazawa, (unknown), (unknown), Takuhisa Okada, (unknown), Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Takehiko Yokobori, Ken Shirabe, (unknown)	3
6	Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy 2023 ·International Journal of Molecular Sciences ·(unknown), Takehiko Yokobori, Makoto Sohda, (unknown), (unknown), (unknown), (unknown), Nobuhiro Nakazawa, (unknown), Takuya Shiraishi, Takuhisa Okada, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Kyoichi Kaira, Ken Shirabe, Hiroshi Saeki	7
7	Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling 2023 ·Oncology ·Nobuhiro Nakazawa, Makoto Sohda, Ayaka Katayama, Munenori Ide, (unknown), (unknown), Takayoshi Watanabe, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, Hiroomi Ogawa, Tetsunari Oyama, Ken Shirabe, (unknown)	1
8	Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity 2023 ·International Journal of Molecular Sciences ·Nobuhiro Nakazawa, Takehiko Yokobori, Makoto Sohda, (unknown), Takayoshi Watanabe, (unknown), Munenori Ide, Akihiko Sano, Makoto Sakai, (unknown), Hiroomi Ogawa, Ken Shirabe, Hiroshi Saeki	4
9	Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer 2022 ·Annals of Gastroenterological Surgery ·Nobuhiro Nakazawa, Makoto Sohda, Takehiko Yokobori, Navchaa Gombodorj, Akihiko Sano, Makoto Sakai, Tetsunari Oyama, Hiroyuki Kuwano, Ken Shirabe, Hiroshi Saeki	5
10	Fibrin/fibrinogen Degradation Products Are Associated With Tumor Stage and Prognosis in Patients Undergoing Resection of Esophageal Cancer 2021 ·Anticancer Research ·Makoto Sakai, Makoto Sohda, (unknown), (unknown), Takayoshi Watanabe, Hideyuki Saito, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, Hiroomi Ogawa, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki	4
11	High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients 2021 ·Oncology ·Nobuhiro Nakazawa, Makoto Sohda, Munenori Ide, (unknown), Yasunari Ubukata, Kengo Kuriyama, Keigo Hara, Akihiko Sano, Makoto Sakai, Takehiko Yokobori, Hiroomi Ogawa, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki	8
12	Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer 2020 ·The American Journal of Surgery ·Makoto Sakai, Makoto Sohda, Hideyuki Saito, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Keigo Hara, Akihiko Sano, Kyoichi Ogata, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki	8
13	Paget’s disease derived in situ from reserve cell hyperplasia, squamous metaplasia, and squamous cell carcinoma of the esophagogastric junction: a case report 2018 ·SHILAP Revista de lepidopterología ·Akihiko Sano, Shinji Sakurai, (unknown), Yuichi Tabe, Kana Saito, Takaharu Fukasawa, Shinsuke Kiriyama, Hideki Yamamoto, Masachika Tani, Hiroshi Naitoh, Ken Shirabe, Hiroyuki Kuwano	2
14	Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer 2014 ·Cancer Chemotherapy and Pharmacology ·Tatsuya Miyazaki, Makoto Sohda, Naritaka Tanaka, Shigemasa Suzuki, Keisuke Ieta, Makoto Sakai, Akihiko Sano, Takehiko Yokobori, Takanori Inose, Masanobu Nakajima, Minoru Fukuchi, Hitoshi Ojima, Hiroyuki Kato, Hiroyuki Kuwano	29
15	MiR‐150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1 2012 ·Cancer Science ·Takehiko Yokobori, Shigemasa Suzuki, Naritaka Tanaka, Takanori Inose, Makoto Sohda, Akihiko Sano, Makoto Sakai, Masanobu Nakajima, Tatsuya Miyazaki, Hiroyuki Kato, Hiroyuki Kuwano	111
16	Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma. 2010 ·PubMed ·Makoto Sakai, Makoto Sohda, Tatsuya Miyazaki, Shigemasa Suzuki, Akihiko Sano, Naritaka Tanaka, Takanori Inose, Masanobu Nakajima, Hiroyuki Kato, Hiroyuki Kuwano	68
17	Quantitative analysis of cisplatin sensitivity of human esophageal squamous cancer cell lines using in‐air micro‐PIXE 2010 ·Cancer Science ·Naritaka Tanaka, Hitoshi Kimura, Ahmad Faried, Makoto Sakai, Akihiko Sano, Takanori Inose, Makoto Sohda, Koji Okada, Masanobu Nakajima, Tatsuya Miyazaki, Minoru Fukuchi, Hiroyuki Kato, Takayuki Asao, Hiroyuki Kuwano, Takahiro Satoh, Masakazu Oikawa, Tomihiro Kamiya, Kazuo Arakawa	13
18	Expression of Lysyl Oxidase Is Correlated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma 2009 ·Annals of Surgical Oncology ·Makoto Sakai, Hiroyuki Kato, Akihiko Sano, Naritaka Tanaka, Takanori Inose, Hitoshi Kimura, Makoto Sohda, Masanobu Nakajima, Hiroyuki Kuwano	36
19	Biomaterials for Gene Delivery Atelocollagen-mediated Controlled Release of Molecular Medicines 2001 ·Current Gene Therapy ·Takahiro Ochiya, Shunji Nagahara, Akihiko Sano, (unknown), Masaaki Terada	111
20	Development of a novel controlled release system for protein drugs using silicone. 1999 ·Drug Delivery System ·(unknown), (unknown), Akihiko Sano, Yasuo Kashiwazaki, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact